[144] ABBVIE INC. SEC Filing

Rhea-AI Filing Summary

AbbVie filed a Form 144 reporting a proposed sale of 42,370 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $8,407,068.11. The filing lists the approximate date of sale as 08/12/2025 and shows the shares were acquired by a stock option exercise on 08/12/2025 with payment in cash.

The notice states there were no securities sold in the past three months by the person for whose account the shares are to be sold. The filing includes the total number of shares outstanding as 1,766,558,253, and identifies the executing broker and the class of security as common stock. No additional transaction context or identities are provided in the document.

Insights

Financial Analyst

TL;DR: Small, routine Form 144 reporting a stock option exercise and proposed sale of 42,370 shares.

This Form 144 documents a proposed sale via Morgan Stanley of 42,370 shares valued at $8.41M and notes acquisition by stock option exercise on the same date. The filing reports no sales in the past three months, and provides outstanding share count. From a market-impact perspective the filing is procedural: it signals a planned disposition following option exercise rather than an unusual market event. The disclosure is complete for the transaction details shown but lacks names or further context.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure showing an option exercise and proposed sale; governance implications are routine.

The form affirms the seller represents no undisclosed material adverse information and records the broker, class, and payment method as cash. It shows the acquisition and proposed sale occurring on 08/12/2025. The absence of other recent sales simplifies aggregation requirements. For governance review, the filing appears to meet Rule 144 procedural content requirements but does not identify the filing individual's role or relationship beyond a generic field, leaving limited governance insight.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	42370	8407068.11	1766558253	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2025	Stock Option Exercise	Issuer			42370	08/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AbbVie's (ABBV) Form 144 report?

The Form 144 reports a proposed sale of 42,370 shares of common stock valued at $8,407,068.11 through Morgan Stanley Smith Barney LLC.

When is the approximate sale date listed on the ABBV Form 144?

The filing lists the approximate date of sale as 08/12/2025.

How were the shares acquired according to the Form 144?

The shares were acquired by a stock option exercise on 08/12/2025, with payment made in cash.

Does the Form 144 show any other sales in the past three months for ABBV?

No. The filing explicitly states Nothing to Report for securities sold during the past three months.

Which broker will handle the proposed ABBV share sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY.